Documentos de Pogosova N. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Origen: "scopus"

Subtipo de publicación

Publisher

European Heart Journal - Cardiovascular Pharmacotherapy(1)

Journal of Clinical Endocrinology and Metabolism(1)

Journal of Stroke(1)

Área temáticas

Enfermedades(2)

Fisiología humana(2)

Cirugía y especialidades médicas afines(1)

Farmacología y terapéutica(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Enfermedad cardiovascular(2)

Epidemiología(1)

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

Apolipoproteins(1)

Case-control(1)

Composite outcome(1)

Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

Abstract: Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which may

Palabras claves:

Apolipoproteins, Case-control, dyslipidemia, Lipoproteins, risk factor, stroke

Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.L., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Hussain F.A., Iqbal R., Iversen H.K., Judge C., Lanas F., Langhorne P., Lisheng L., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’donnell M.J., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Sniderman A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.

Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial

Abstract: Context: Low cognitive scores are risk factors for cardiovascular outcomes. Whether this relationshi

Palabras claves:

cardiovascular events, cognitive impairment, Composite outcome, death, Geometric mean, MACE, risk factor, stroke

Angelyn Bethel M., Basile J.N., Cardona-Munoz E.G., Conget I., Cukierman-Yaffee T., Dagenais G.R., Franek E., Gerstein H.C., Hall S., Hâncu N., Jansky P., Lakshmanan M., Lanas F., Leiter L.A., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Ramasundarahettige C., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu H.H., Temelkova-Kurktschiev T.

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

Abstract: Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheral

Palabras claves:

aspirin, Coronary artery disease, Peripheral artery disease, rivaroxaban

Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhatt D.L., Bosch J.J., Branch K.R.H., Camillo Felix, Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.L., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Guzik T.J., Hori M., Ibrahim K.S., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Lopez-Jaramillo P., Maggioni A.P., Metsarinne K.P., Muehlhofer E., Neumann C., O’Donnell M., Parkhomenko A.N., Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Stoerk S., Tasto C., Tonkin A.M., Torp-Pedersen C., Tyrwitt J., Vanassche T., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yusuf S., Zhu J.